I feel that it is acceptable to take the risk of a clinical trial when the results of the trial are expected to either benefit or not affect those involved. This would be in the case of testing an intervention that can be supported by pre-clinical trials to have the ability to positively impact the patient. It is not ethical to deny an established treatment in order to test a new one. Often times, those that sign up for risky clinical trials are those who choose to do so after exhausting their other treatment options. Because we need the trials to provide for the health needs of the community, so long as there is consent and transparency, I feel that it is ethical to conduct the trials.

I feel that this is not an attack on their basic freedoms because it is only a blockade on companies/groups that wish to maintain their certifications and clearances. It is the duty of the regulating bodies to protect the general public from possible harm, and this includes harm that can come about from making a decision that is misinformed. Of course, if someone is adamant about seeking a risky treatment option, there are avenues to avoid regulating bodies. However, it is important to make sure that the regulating bodies do all that they can to preserve the health of the public.